Astellas Pharma, Inc.(ALPMF)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

ALPMF Astellas Pharma, Inc.

交易中 04-27 16:00:00 EDT 延时

{"stockData":{"symbol":"ALPMF","market":"US","secType":"STK","nameCN":"Astellas Pharma, Inc.","latestPrice":15.6,"timestamp":1777320000000,"preClose":15.6,"halted":0,"volume":0,"delay":15,"changeRate":0,"floatShares":1731101601,"shares":1861787075,"eps":0.074352,"marketStatus":"交易中","change":0,"latestTime":"04-27 16:00:00 EDT 延时","open":15.6,"high":15.6,"low":15.6,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"otc":true,"ttmEps":0.074352,"tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1777406400000},"marketStatusCode":2,"adr":0,"adrRate":0,"exchange":"PINK LIMITED","adjPreClose":15.6,"volumeRatio":0.03306878088169438},"requestUrl":"/m/hq/s/ALPMF","defaultTab":"news","newsList":[{"id":"2628747934","title":"辉瑞与安斯泰来Padcev联合Keytruda膀胱癌适应症获FDA优先审评","url":"https://stock-news.laohu8.com/highlight/detail?id=2628747934","media":"金吾财讯","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2628747934?lang=zh_cn&edition=full","pubTime":"2026-04-20 19:29","pubTimestamp":1776684597,"startTime":"0","endTime":"0","summary":"金吾财讯 | 辉瑞 与安斯泰来周一宣布，双方合作开发的抗体药物偶联物 Padcev 联合默沙东抗 PD-1 疗法 Keytruda 用于治疗膀胱癌的上市申请，已获得美国 FDA 优先审评资格。此次申请旨在将该联合疗法的适用人群扩展至所有肌层浸润性膀胱癌患者，不再受限于是否耐受顺铂的化疗。早在去年 11 月，FDA 已批准该组合疗法用于术前及术后，治疗无法接受顺铂化疗的肌层浸润性膀胱癌患者。FDA 将 2026 年 8 月 17 日定为此次补充生物制品许可申请的目标审批日期。","market":"sg","thumbnail":"https://static.szfiu.com/news/20250107/Nzg4NjU0MjU3NDIxMDY0.png","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250107/Nzg4NjU0MjU3NDIxMDY0.png"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"299435","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4534","IE00BLSP4239.USD","LU1093756325.SGD","LU0122379950.USD","IE00B19Z3B42.SGD","BK4550","ALPMF","IE0002141913.USD","LU0859254822.USD","LU1069347547.HKD","LU0006306889.USD","LU1585245621.USD","MRK","IE000M9KFDE8.USD","LU0265550946.USD","LU0266013472.USD","LU2468319806.SGD","LU1894683264.USD","BK4516","LU2112291526.USD","LU1066051498.USD","IE00BJJMRZ35.SGD","LU0861579265.USD","LU1934455277.USD","SG9999015341.SGD","SG9999002224.SGD","PFE","SG9999013999.USD","BK4592","LU1057294990.SGD","LU0321505868.SGD","IE00BLSP4452.SGD","BK4568","LU2361044865.SGD","LU2089984988.USD","LU0306806265.USD","IE00BFTCPJ56.SGD","LU1929549753.HKD","LU1883839398.USD","LU0130517989.USD","IE00BJT1NW94.SGD","LU1699723380.USD","LU1116320737.USD","BK4585","LU1061106388.HKD","LU0648001328.SGD","SG9999003800.SGD","LU2324357040.USD","BK4581","LU0211331839.USD","LU2125154935.USD","LU0203347892.USD","LU1116320901.HKD","LU1974910355.USD","LU0477156953.USD","SG9999014575.USD","BK4599","SG9999001440.SGD","LU0203345920.USD","LU1430594728.SGD","LU0868494617.USD","LU0942090050.USD","LU2023250504.SGD","SG9999015358.SGD","LU0130102774.USD","LU1066053197.SGD","LU1941712264.USD","LU0320765646.SGD","LU0225771236.USD","LU1066051811.HKD","LU2361044949.HKD","LU2360032135.SGD","LU0170899867.USD","LU1917777945.USD","LU1571399168.USD","BK4007","SG9999011175.SGD","LU0432979614.USD","LU1066051225.USD","LU0965509010.AUD","LU1894683348.USD","IE00B19Z3581.USD","LU0320765489.SGD","SGXZ57979304.SGD","LU0058720904.USD","LU0238689110.USD","LU0208291251.USD","BK4588","IE00B2B36J28.USD","LU0106261372.USD","LU0225284248.USD","LU0980610538.SGD","LU1291159041.SGD","IE00B4R5TH58.HKD","LU0321505439.SGD","SG9999001176.SGD","LU1989772923.USD","IE0009355771.USD","LU1162221912.USD","LU0456855351.SGD","IE0002270589.USD","LU2461242641.AUD","LU2125154778.USD","LU0265550359.USD","IE00BN8TJ469.HKD","IE00B1BXHZ80.USD","LU1023059063.AUD","LU1035773651.USD","LU1989772840.SGD","LU1941712348.USD","LU0868494708.USD","LU1934455194.USD","SG9999002232.USD","SG9999014559.SGD","LU0306807586.USD","SG9999014542.SGD","LU1093756168.USD","LU0965509101.SGD","LU2023250843.SGD","LU0985481810.HKD","LU1037948541.HKD","IE00BBT3K403.USD","LU0965508806.USD","LU0289739699.SGD","BK4533","BK4559","LU1983299246.USD","LU2361045086.USD","LU0985320562.USD","IE00BSNM7G36.USD","SG9999014567.USD","LU2106854487.HKD","LU1201861249.SGD","LU0098860793.USD","LU1037948897.HKD","LU0965509283.SGD","LU1989771016.USD","LU2357627491.SGD","SG9999001176.USD","LU0070302665.USD","LU0234572021.USD","LU1934455863.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1159770601","title":"安斯泰来制药：FDA根据《处方药使用者费用法案》设定2026年8月17日为关键审批日期","url":"https://stock-news.laohu8.com/highlight/detail?id=1159770601","media":"美股速递","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1159770601?lang=zh_cn&edition=full","pubTime":"2026-04-20 18:48","pubTimestamp":1776682090,"startTime":"0","endTime":"0","summary":"根据《处方药使用者费用法案》框架，美国食品药品监督管理局已为安斯泰来制药的核心新药申请划定重要时间节点——2026年8月17日被正式确立为监管审评的目标行动日期。这一关键时间点的设定，标志着该创新疗法的审评进程进入倒计时阶段，为市场预期提供了明确的时间坐标。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1894683264.USD","SGXZ57979304.SGD","LU0321505439.SGD","ALPMY","LU0321505868.SGD","LU0456855351.SGD","IE00BLSP4452.SGD","LU0306807586.USD","BK4581","LU0170899867.USD","SG9999001176.USD","SG9999003800.SGD","IE00B19Z3B42.SGD","BK4534","LU0122379950.USD","SG9999002232.USD","LU1883839398.USD","LU1057294990.SGD","SG9999001176.SGD","SG9999013999.USD","BK4568","LU0289739699.SGD","BK4585","LU0306806265.USD","BK4588","IE00BBT3K403.USD","LU1066051498.USD","BK4007","LU1066053197.SGD","ALPMF","SG9999011175.SGD","LU0058720904.USD","BK4550","IE000M9KFDE8.USD","LU0868494617.USD","LU1894683348.USD","LU0225284248.USD","IE00B19Z3581.USD","LU0234572021.USD","IE0002270589.USD","BK4533","IE00BLSP4239.USD","SG9999002224.SGD","LU0985481810.HKD","LU0225771236.USD","BK4592","BK4599","LU1023059063.AUD"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.astellas.com/en/index.html","stockEarnings":[{"period":"1week","weight":0.0034},{"period":"1month","weight":0.0549},{"period":"3month","weight":-0.0236},{"period":"6month","weight":-0.0147},{"period":"1year","weight":-0.1856},{"period":"ytd","weight":0.0926}],"exchange":"PINK LIMITED","name":"Astellas Pharma, Inc.","nameEN":"Astellas Pharma, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.42.0","shortVersion":"4.42.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Astellas Pharma, Inc.(ALPMF)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Astellas Pharma, Inc.(ALPMF)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Astellas Pharma, Inc.,ALPMF,Astellas Pharma, Inc.股票,Astellas Pharma, Inc.股票老虎,Astellas Pharma, Inc.股票老虎国际,Astellas Pharma, Inc.行情,Astellas Pharma, Inc.股票行情,Astellas Pharma, Inc.股价,Astellas Pharma, Inc.股市,Astellas Pharma, Inc.股票价格,Astellas Pharma, Inc.股票交易,Astellas Pharma, Inc.股票购买,Astellas Pharma, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Astellas Pharma, Inc.(ALPMF)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Astellas Pharma, Inc.(ALPMF)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}